A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins

Completed · Phase 2 · Has a placebo group

Conditions studied: Hypercholesterolemia, Dyslipidemia

In brief

This study will investigate the effect of PF-04950615, a new investigational lipid lowering agent, on LDL-C and other lipids.

Key facts

Study ID

NCT01342211

Run by

Pfizer

People needed

93

Starts

2011-07-01

Expected to finish

2012-06-01

Last updated by the study team

2017-10-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• On a stable daily dose of atorvastatin, rosuvastatin or simvastatin.
• Lipids meet the following criteria at screening and prior to dosing: Fasting LDL-C greater than 100 mg/dL and fasting TG less than 400 mg/dL

You may not qualify if…

• History of a cardiovascular or cerebrovascular event or procedure during the past year.
• Poorly controlled type 1 or type 2 diabetes mellitus.
• Poorly controlled hypertension.

Where it is running

• Orange County Research Center — Tustin, California, United States
• Diablo Clinical Research, Inc. — Walnut Creek, California, United States
• Innovative Research of West Florida, Inc. — Clearwater, Florida, United States
• Avail Clinical Research, LLC — DeLand, Florida, United States
• In Vivo Clinical Research, Inc. — Doral, Florida, United States
• Jacksonville Center for Clinical Research — Jacksonville, Florida, United States
• Kendall South Medical Center — Miami, Florida, United States
• North Georgia Clinical Research — Woodstock, Georgia, United States
• North Georgia Internal Medicine — Woodstock, Georgia, United States
• Vince and Associates Clinical Research — Overland Park, Kansas, United States
• Heartland Research Associates, LLC — Wichita, Kansas, United States
• L-MARC Research Center — Louisville, Kentucky, United States
• Commonwealth Biomedical Research, LLC — Madisonville, Kentucky, United States
• Maine Research Associates — Auburn, Maine, United States
• Infinity Medical Research — North Dartmouth, Massachusetts, United States
• Saint Luke's Hospital — Kansas City, Missouri, United States
• Saint Luke's Lipid and Diabetes Research Center — Kansas City, Missouri, United States
• The Center for Pharmaceutical Research, P.C. — Kansas City, Missouri, United States
• Medex Healthcare Research, Inc. — St Louis, Missouri, United States
• New Mexico Clinical Research & Osteoporosis Center, Incorporated — Albuquerque, New Mexico, United States
• North Carolina Clinical Research — Raleigh, North Carolina, United States
• PMG Research of Salisbury — Salisbury, North Carolina, United States
• Lynn Health Science Institute — Oklahoma City, Oklahoma, United States
• Oklahoma Cardiovascular Research Group (OCRG) — Oklahoma City, Oklahoma, United States
• Oklahoma Heart Hospital Physicians — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.